Biostar Pharmaceutic (BSPM) - NASDAQ
  • Tue, May 24, 6:48 AM
    • Biostar Pharmaceuticals (BSPM) Q1 results: Revenues: $0.8M (-88.4%); Operating Expense: $1M (-77.8%); Operating Loss: ($0.7M) (+22.2%); Net Loss: ($0.6M) (-200.0%); Loss Per Share: ($0.28) (-300.0%); Quick Assets: $0.09M (+125.0%); CF Ops: $0.3M (-89.3%).
    • No guidance given.
    | Tue, May 24, 6:48 AM
  • Mon, May 23, 4:04 PM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): Q1 EPS of -$0.28
    • Revenue of $0.8M (-88.4% Y/Y)
    • Press Release
    | Mon, May 23, 4:04 PM
  • Fri, Apr. 15, 7:23 AM
    • Biostar Pharmaceuticals (BSPM) FY15 results: Revenues: $27.1M (-55.9%); R&D Expense: $4M (+42.9%); SG&A: $13.3M (-49.2%); Operating Loss: ($23.8M) (-999%); Net Loss: ($25.1M) (-622.9%); Loss Per Share: ($11.40) (-595.7%); Quick Assets: $0.04M (-97.6%).
    • No guidance given.
    | Fri, Apr. 15, 7:23 AM
  • Thu, Apr. 14, 4:05 PM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): FY15 EPS of -$11.40
    • Revenue of $27.12M (-55.8% Y/Y)
    • Press Release
    | Thu, Apr. 14, 4:05 PM
  • Nov. 24, 2015, 8:23 AM
    • Biostar Pharmaceuticals (BSPM -0.8%) Q3 results: Revenues: $4.2M (-71.4%); Operating Expense: $2.5M (-63.2%); Operating Loss: ($1.7M) (-950.0%); Net Loss: ($1.3M) (-750.0%); Loss Per Share: ($0.08) (-500.0%); Quick Assets: $0.1M (-94.1%).
    • No guidance given.
    | Nov. 24, 2015, 8:23 AM
  • Nov. 23, 2015, 4:10 PM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): Q3 EPS of -$0.08
    • Revenue of $4.2M (-71.3% Y/Y)
    | Nov. 23, 2015, 4:10 PM
  • Aug. 20, 2015, 8:42 AM
    • Biostar Pharmaceuticals (BSPM) Q2 results: Revenues: $14.2M (-26.0%); COGS: $8.2M (-17.2%); Operating Expenses: $7M (-2.8%); Operating Loss: ($1.1M) (-320.0%); Net Loss: ($0.5M) (-131.3%); Loss Per Share: ($0.03) (-127.3%); Quick Assets: $0.3M (-82.4%); CF Ops: $0.5M (-50.0%).
    • No guidance given.
    | Aug. 20, 2015, 8:42 AM
  • Aug. 19, 2015, 4:37 PM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): Q2 EPS of -$0.03
    • Revenue of $14.17M (-26.2% Y/Y)
    | Aug. 19, 2015, 4:37 PM
  • May 15, 2015, 4:53 PM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): Q1 EPS of -$0.01 vs. $0.02 in 1Q14
    • Revenue of $6.9M (-47.3% Y/Y)
    | May 15, 2015, 4:53 PM
  • Apr. 16, 2015, 8:17 AM
    • Biostar Pharmaceuticals (BSPM -0.8%) FY14 results: Revenues: $61.4M (+16.5%); COGS: $31.1M (+15.2%); R&D Expense: $2.8M (-12.5%); SG&A: $17.6M (+16.6%); Operating Loss: ($1.3M) (-360.0%); Net Income: $4.8M (+500.0%); EPS: $0.33 (+371.4%); Quick Assets: $1.7M (+999%).
    • No guidance given.
    | Apr. 16, 2015, 8:17 AM
  • Apr. 15, 2015, 4:37 PM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): FY'14 EPS of $0.33.
    • Revenue of $61.4M (+16.3% Y/Y).
    | Apr. 15, 2015, 4:37 PM
  • Nov. 14, 2014, 10:00 AM
    • Biostar Pharmaceuticals (BSPM -22%) Q3 results: Revenues: $14.7M (-2.0%); COGS: $7.7M (-4.9%); Operating Expenses: $6.8M (+9.7%); Net Income: $0.2M (-50.0%); EPS: $0.02 (-33.3%); Quick Assets: $7.8M (+999%); CF Ops: ($0.5M) (-103.6%).
    • No guidance given.
    | Nov. 14, 2014, 10:00 AM
  • Nov. 14, 2014, 9:08 AM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): Q3 EPS of $0.02.
    • Revenue of $14.65M (-2.3% Y/Y).
    • Shares -10.4% PM.
    | Nov. 14, 2014, 9:08 AM
  • Aug. 14, 2014, 9:20 AM
    • Biostar Pharmaceuticals (NASDAQ:BSPM) Q2 results: Revenues: $19.2M (+30.6%); Operating Income: $455.3K (+157.3%); Net Income: $1.7M (+725.9%); EPS: $0.11 (+283.3%); Quick Assets: $9.3M (999%); CF Ops (1H): $1.0M (-90.2%).
    • No financial guidance given.
    | Aug. 14, 2014, 9:20 AM
  • Aug. 14, 2014, 8:47 AM
    • Biostar Pharmaceuticals (NASDAQ:BSPM): Q2 EPS of $0.11.
    • Revenue of $19.2M (+31.1% Y/Y).
    • Shares +22% PM.
    | Aug. 14, 2014, 8:47 AM
Company Description
BioStar Pharmaceuticals, Inc., develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The company's products include AoXing Oleanlic Acid Capsule (treatment for Hepatitis B), Danshen Granule (treatment for coronory heart... More
Sector: Healthcare
Industry: Drug Manufacturers - Major
Country: United States